Expanded Access Policy
At GenEditBio, our mission is to develop fundamentally safe, efficacious, and affordable in vivo genome-editing therapies for genetic diseases with unmet medical needs.
Expanded access, sometimes called “compassionate use”, is a potential regulatory pathway for a patient with a serious or life-threatening disease or condition to gain access to an investigational medical product (drug, biologic, or medical device) for treatment outside of clinical trials when no comparable or satisfactory alternative therapy options are available. While GenEditBio appreciates the intent of expanded access, at this time, we do not offer access to our investigational therapies outside of clinical trials. Participation in clinical trials is currently the only mechanism by which patients can gain access to our investigational therapies.
This decision is based on two key considerations:
1. Requirement for robust clinical data: Further scientific evaluation in rigorous clinical trials is needed to establish the safety and efficacy of our investigational therapies.
2. Investigational supply: Our current supply of investigational therapies is fully dedicated to supporting active and planned clinical trials necessary for regulatory submissions.
We believe the most appropriate way to access our investigational therapies is through participation in our clinical trials. For a listing of our clinical trials, please visit here (clicking the link will bring you to the external site ClinicalTrials.gov). For additional information, please contact our Clinical Trials Information Center at clinicaltrials@geneditbio.com or speak with your physician. We will acknowledge receipt of requests sent to this email address within five business days.
GenEditBio conducts regular reviews of this policy and reserves the right to revise it at any time.
Last reviewed: September 22, 2026
Last updated: September 22, 2026
Copyright © 2025 GenEditBio
Provide affordable precision DNA surgery for genetic diseases with unmet needs
Business Contact bd@geneditbio.com
Media Contact geb.media@geneditbio.com
HONG KONG Unit 101-102, Building 6W, 6 Science Park West Avenue, Hong Kong hkoffice@geneditbio.com
BEIJING 4/F, Building 29, Yard 18, Kechuang 13th St, VPark, Beijing